Published in Iran J Basic Med Sci on October 01, 2013
Characterization of Encapsulated Berberine in Yeast Cells of Saccharomyces cerevisiae. Iran J Pharm Res (2015) 0.87
Investigation of the Best Saccharomyces cerevisiae Growth Condition. Electron Physician (2017) 0.75
Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv Drug Deliv Rev (2001) 1.77
Stability study of amorphous valdecoxib. Int J Pharm (2004) 1.18
Quantitative measurement of indomethacin crystallinity in indomethacin-silica gel binary system using differential scanning calorimetry and X-ray powder diffractometry. AAPS PharmSciTech (2006) 0.91
Development of directly compressible powders via co-spray drying. Eur J Pharm Biopharm (2007) 0.90
Increasing the aqueous solubility of acetaminophen in the presence of polyvinylpyrrolidone and investigation of the mechanisms involved. Drug Dev Ind Pharm (2003) 0.87
Highly compressible paracetamol: I: crystallization and characterization. Int J Pharm (2000) 0.86
Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30. Pharm Dev Technol (2008) 0.86
A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions. Drug Dev Ind Pharm (2011) 0.86
Development of spray-dried acetaminophen microparticles using experimental designs. Int J Pharm (2000) 0.84
Acetaminophen particle design using chitosan and a spray-drying technique. Chem Pharm Bull (Tokyo) (2005) 0.83
Effect of polymer content and molecular weight on the morphology and heat- and moisture-induced transformations of spray-dried composite particles of amorphous lactose and poly(vinylpyrrolidone). Pharm Res (2003) 0.81
Highly compressible paracetamol - II. Compression properties. Int J Pharm (2000) 0.81
Preparation, characterization, and in vitro intestinal permeability evaluation of thalidomide-hydroxypropyl-β-cyclodextrin complexes. AAPS PharmSciTech (2011) 0.81
Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process. Eur J Pharm Biopharm (2007) 0.80
Effect of amorphous content on dissolution characteristics of rifampicin. Drug Dev Ind Pharm (2008) 0.80
Dissolution and solid-state characterization of poorly water-soluble drugs in the presence of a hydrophilic carrier. AAPS PharmSciTech (2011) 0.80
The effect of spray drying solutions of polyethylene glycol (PEG) and lactose/PEG on their physicochemical properties. Int J Pharm (2002) 0.80
The effect of co-spray drying with polyethylene glycol 4000 on the crystallinity and physical form of lactose. Int J Pharm (2001) 0.80
Spray drying for generation of a ternary amorphous system of celecoxib, PVP, and meglumine. Pharm Dev Technol (2005) 0.78
Compression behaviour and tablet-forming ability of spray-dried amorphous composite particles. Eur J Pharm Sci (2004) 0.78
Temperature-induced crystallization and compactibility of spray dried composite particles composed of amorphous lactose and various types of water-soluble polymer. Chem Pharm Bull (Tokyo) (2000) 0.78
Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers. Acta Pharm (2007) 0.78
Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs. Eur J Pharm Biopharm (2007) 0.78
Effects of Kollicoat IR and hydroxypropyl-beta-cyclodextrin on the dissolution rate of omeprazole from its microparticles and enteric-coated capsules. Pharm Dev Technol (2010) 0.78
The influence of PVP incorporation on moisture-induced surface crystallization of amorphous spray-dried lactose particles. Int J Pharm (2006) 0.77
Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods. Iran J Pharm Res (2015) 0.79
Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP. Eur J Pharm Biopharm (2014) 0.78
Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers. Iran J Basic Med Sci (2014) 0.75